SD Biosensor Valuation Multiples

SD Biosensor is valued at $604M as of October 2026, a 0.9x revenue multiple. In the last fiscal year, SD Biosensor revenue was $530M and SD Biosensor EBITDA was ($522M).

SD Biosensor Overview

About SD Biosensor

SD Biosensor Inc is an in vitro diagnostic company. It aims to contribute to the improvement of quality of life through rapid and accurate disease diagnosis. It is researching and developing quick diagnostics, immunodiagnostics, molecular diagnostics, blood glucose monitoring systems for self -testing.


Founded

1999

HQ

South Korea

Employees

N/A

Financials (Last FY)

Revenue: $530M
EBITDA: ($522M)

EV

$486M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

SD Biosensor Financials

SD Biosensor reported last fiscal year revenue of $530M and negative EBITDA of ($522M).

In the same fiscal year, SD Biosensor generated $243M in gross profit, ($522M) in EBITDA losses, and had net loss of ($382M).


SD Biosensor P&L

In the most recent fiscal year, SD Biosensor reported revenue of $530M and EBITDA of ($522M).

SD Biosensor is unprofitable as of last fiscal year, with gross margin of 46%, EBITDA margin of (98%), and net margin of (72%).

See analyst estimates for SD Biosensor
Last FY202320242025202620272028
Revenue$530M$488M$517M$530M
Gross Profit$243M$94M$253M$243M
Gross Margin46%19%49%46%
EBITDA($522M)($205M)($23M)($522M)
EBITDA Margin(98%)(42%)(4%)(98%)
EBIT Margin(11%)(38%)(8%)(11%)
Net Profit($382M)($348M)($73M)($382M)
Net Margin(72%)(71%)(14%)(72%)
Net Debt$218M---

Financial data powered by Morningstar, Inc.

SD Biosensor Stock Performance

SD Biosensor has current market cap of $604M, and enterprise value of $486M.

Market Cap Evolution


SD Biosensor's stock price is $5.05.

SD Biosensor share price increased by 11.6% in the last 30 days, and decreased by 24.4% in the last year.

SD Biosensor has an EPS (earnings per share) of $-3.19.

See more trading valuation data for SD Biosensor
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$486M$604M2.2%11.6%13.9%-24.4%$-3.19

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

SD Biosensor Valuation Multiples

SD Biosensor trades at 0.9x EV/Revenue multiple, and (0.9x) EV/EBITDA.

See NTM and 2027E valuation multiples for SD Biosensor

SD Biosensor Financial Valuation Multiples

As of October 17, 2026, SD Biosensor has market cap of $604M and EV of $486M.

SD Biosensor has a P/E ratio of (1.6x).

Last FY202320242025202620272028
EV/Revenue0.9x1.0x0.9x0.9x
EV/EBITDA(0.9x)(2.4x)(20.9x)(0.9x)
EV/EBIT(8.0x)(2.6x)(12.1x)(8.0x)
EV/Gross Profit2.0x5.2x1.9x2.0x
P/E(1.6x)(1.7x)(8.2x)(1.6x)
EV/FCF2.2x(1.7x)8.6x2.2x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified SD Biosensor Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

SD Biosensor Margins & Growth Rates

In the most recent fiscal year, SD Biosensor reported gross margin of 46%, EBITDA margin of (98%), and net margin of (72%).

See estimated margins and future growth rates for SD Biosensor

SD Biosensor Margins

Last FY20242025202720282029
Gross Margin46%49%46%
EBITDA Margin(98%)(4%)(98%)
EBIT Margin(11%)(8%)(11%)
Net Margin(72%)(14%)(72%)
FCF Margin42%11%42%

SD Biosensor Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth6%3%
Gross Profit Growth169%(4%)
EBITDA Growth(89%)2148%
EBIT Growth(78%)50%
Net Profit Growth(79%)422%
FCF Growth(120%)298%

Data powered by FactSet, Inc. and Morningstar, Inc.

SD Biosensor Operational KPIs

Access forward-looking KPIs for SD Biosensor
Last FY202320242025202620272028
S&M Expenses to Revenue11%13%9%11%
G&A Expenses to Revenue4%3%3%4%
R&D Expenses to Revenue11%10%13%11%
Opex to Revenue57%57%57%57%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

SD Biosensor Competitors

SD Biosensor competitors include Nanosonics, Anteris Technologies US, OrthoPediatrics, MiMedx Group, Lumibird, Barco, The Beauty Tech Group, Sunmax Biotechnology, Medistim and IBA Group.

Most SD Biosensor public comparables operate across Medical Devices, DeepTech and HealthTech.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Nanosonics$142M$17M3.5x3.4x29.3x30.8x
Anteris Technologies US$2M($93M)176.1x64.8x(3.6x)(2.9x)
OrthoPediatrics$236M($12M)2.7x2.4x(52.0x)27.4x
MiMedx Group$419M$78M1.3x1.8x6.8x30.1x
Lumibird$257M$47M2.5x2.4x13.9x11.5x
Barco$1.1B$137M0.6x0.6x5.0x5.2x
The Beauty Tech Group$187M$37M3.2x2.7x16.3x9.5x
Sunmax Biotechnology$63M$34M10.3x-18.8x-

This data is available for Pro users. Sign up to see all SD Biosensor competitors and their valuation data.

Start Free Trial

Acquisitions by SD Biosensor

SD Biosensor has acquired 1 company to date.

Last acquisition by SD Biosensor was on July 7th 2022. SD Biosensor acquired Meridian Bioscience for $1.5B (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by SD Biosensor

Meridian Bioscience
Description
Meridian Bioscience is a Cincinnati-headquartered life sciences company developing diagnostic tests for infectious diseases including gastrointestinal, respiratory, viral, and parasitic conditions. Operating in U.S. Diagnostics, European Diagnostics, and Life Science segments, it manufactures antigens, antibodies, PCR reagents, and contract biologics under cGMP standards. Products support clinical labs, researchers, and biopharma developers worldwide.
HQ CountryUnited States
HQ City
Cincinnati, OH
Deal Date7 Jul 2022
Valuation$1.5B
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all SD Biosensor acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About SD Biosensor

When was SD Biosensor founded?SD Biosensor was founded in 1999.
Where is SD Biosensor headquartered?SD Biosensor is headquartered in South Korea.
Is SD Biosensor publicly listed?Yes, SD Biosensor is a public company listed on Korea Exchange.
What is the stock symbol of SD Biosensor?SD Biosensor trades under 137310 ticker.
When did SD Biosensor go public?SD Biosensor went public in 2021.
Who are competitors of SD Biosensor?SD Biosensor main competitors include Nanosonics, Anteris Technologies US, OrthoPediatrics, MiMedx Group, Lumibird, Barco, The Beauty Tech Group, Sunmax Biotechnology, Medistim, IBA Group.
What is the current market cap of SD Biosensor?SD Biosensor's current market cap is $604M.
What is the current revenue of SD Biosensor?SD Biosensor's last fiscal year revenue is $530M.
What is the current EV/Revenue multiple of SD Biosensor?Current revenue multiple of SD Biosensor is 0.9x.
Is SD Biosensor profitable?No, SD Biosensor is not profitable.
How many companies SD Biosensor has acquired to date?As of October 2026, SD Biosensor has acquired 1 company.
What was the largest acquisition by SD Biosensor?$1.5B acquisition of Meridian Bioscience on 7th July 2022 was the largest M&A SD Biosensor has done to date.
What companies SD Biosensor acquired?SD Biosensor acquired Meridian Bioscience.
In how many companies SD Biosensor has invested to date?SD Biosensor hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to SD Biosensor

Lists including SD Biosensor

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial